350% rally in 3 years, multibagger pharma stock to be in focus on Wednesday | Key details from filing
New Delhi, Sept. 15 -- Shares of Sudarshan Pharma Industries are likely to attract investors' interest on Wednesday, September 16, after the company said the proposal to acquire a 9.50% equity stake in MedTherapy Biotechnology Inc., USA, remains under due diligence, while confirmation and a board r…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.